SLC2A1 and neoplasm: Likewise, anergic T cells and dysfunctional tumor infiltrating lymphocytes are reported to have defects in glycolytic pathway31–33 and deficiency in glucose transporter glut1 has been linked with decreased effector function and protection from inflammatory diseases34.